$0.44 EPS Expected for Pra Group (PRAA); Akorn (AKRX) Shorts Increased By 23.62%

October 13, 2017 - By Marie Mckinney

Analysts expect Pra Group Inc (NASDAQ:PRAA) to report $0.44 EPS on November, 6.They anticipate $0.24 EPS change or 35.29% from last quarter’s $0.68 EPS. PRAA’s profit would be $19.92 million giving it 16.32 P/E if the $0.44 EPS is correct. After having $0.25 EPS previously, Pra Group Inc’s analysts see 76.00% EPS growth. About 228,257 shares traded. Pra Group Inc (NASDAQ:PRAA) has risen 44.62% since October 13, 2016 and is uptrending. It has outperformed by 27.92% the S&P500.

Akorn Incorporated (NASDAQ:AKRX) had an increase of 23.62% in short interest. AKRX’s SI was 19.29M shares in October as released by FINRA. Its up 23.62% from 15.61 million shares previously. With 3.41M avg volume, 6 days are for Akorn Incorporated (NASDAQ:AKRX)’s short sellers to cover AKRX’s short positions. The SI to Akorn Incorporated’s float is 23.74%. About 1.10 million shares traded. Akorn, Inc. (NASDAQ:AKRX) has risen 12.04% since October 13, 2016 and is uptrending. It has underperformed by 4.66% the S&P500.

Among 6 analysts covering Portfolio Recovery Associates (NASDAQ:PRAA), 2 have Buy rating, 2 Sell and 2 Hold. Therefore 33% are positive. Portfolio Recovery Associates had 13 analyst reports since October 14, 2015 according to SRatingsIntel. As per Tuesday, June 7, the company rating was initiated by First Analysis. The stock of Pra Group Inc (NASDAQ:PRAA) has “Buy” rating given on Wednesday, August 9 by Keefe Bruyette & Woods. On Thursday, September 14 the stock rating was maintained by Keefe Bruyette & Woods with “Buy”. Raymond James downgraded Pra Group Inc (NASDAQ:PRAA) on Tuesday, May 10 to “Outperform” rating. Raymond James downgraded Pra Group Inc (NASDAQ:PRAA) on Tuesday, November 8 to “Mkt Perform” rating. The company was downgraded on Tuesday, October 10 by Keefe Bruyette & Woods. The rating was downgraded by Raymond James to “Underperform” on Thursday, September 21. The rating was downgraded by Janney Capital to “Sell” on Wednesday, October 4. The company was upgraded on Tuesday, November 17 by Raymond James. The rating was downgraded by JMP Securities to “Mkt Perform” on Friday, February 26.

PRA Group, Inc. is a financial and business services firm with activities in the Americas and Europe. The company has market cap of $1.30 billion. The Company’s primary business is the purchase, collection and management of portfolios of nonperforming loans. It has a 17.46 P/E ratio. The Firm operates through the account receivables management segment.

Investors sentiment increased to 1.36 in Q2 2017. Its up 0.47, from 0.89 in 2017Q1. It increased, as 26 investors sold Pra Group Inc shares while 54 reduced holdings. 32 funds opened positions while 77 raised stakes. 47.77 million shares or 3.10% more from 46.33 million shares in 2017Q1 were reported. Manufacturers Life Insur The has 35,709 shares. Tygh Cap Management Incorporated stated it has 1.07% in Pra Group Inc (NASDAQ:PRAA). Quantbot Technologies L P holds 0.01% or 3,348 shares. Proshare Advisors Ltd Com owns 11,354 shares. Moreover, Price T Rowe Assocs Inc Md has 0% invested in Pra Group Inc (NASDAQ:PRAA). Ls Invest Advisors stated it has 0% in Pra Group Inc (NASDAQ:PRAA). Great West Life Assurance Can owns 67,251 shares. Timber Creek Cap Mngmt Limited Liability invested in 0.02% or 750 shares. The Pennsylvania-based Pnc Fincl Ser Group Inc has invested 0.09% in Pra Group Inc (NASDAQ:PRAA). Cooke Bieler L P, a Pennsylvania-based fund reported 1.14M shares. Tiaa Cref Inv Mgmt Limited Liability reported 125,002 shares. Credit Suisse Ag holds 19,728 shares or 0% of its portfolio. First Personal Fincl holds 1,001 shares. Pitcairn stated it has 11,442 shares. Teachers Retirement Of The State Of Kentucky reported 0.01% of its portfolio in Pra Group Inc (NASDAQ:PRAA).

Since May 23, 2017, it had 1 buy, and 0 insider sales for $4.91 million activity. Olsen Geir also bought $4.91 million worth of Pra Group Inc (NASDAQ:PRAA) shares.

Akorn Inc. , together with its subsidiaries, is a specialty generic pharmaceutical firm that develops, makes and markets generic and branded prescription pharmaceuticals, as well as private-label over-the-counter (OTC) consumer health products and animal health pharmaceuticals. The company has market cap of $4.15 billion. The Firm operates through two divisions: Prescription Pharmaceuticals and the Consumer Health. It has a 33.6 P/E ratio. The Prescription Pharmaceuticals segment consists of generic and branded prescription pharmaceuticals in a range of dosage forms, including sterile ophthalmics, injectables and inhalants and non-sterile oral liquids, topicals and nasal sprays and otics.

Among 16 analysts covering Akorn Inc (NASDAQ:AKRX), 5 have Buy rating, 2 Sell and 9 Hold. Therefore 31% are positive. Akorn Inc had 33 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Hold” rating given on Friday, May 26 by Jefferies. The rating was upgraded by Piperjaffray on Thursday, September 15 to “Overweight”. The stock of Akorn, Inc. (NASDAQ:AKRX) earned “Hold” rating by Deutsche Bank on Friday, August 5. The stock of Akorn, Inc. (NASDAQ:AKRX) has “Market Perform” rating given on Wednesday, March 23 by Leerink Swann. RBC Capital Markets maintained the shares of AKRX in report on Friday, September 1 with “Hold” rating. The stock of Akorn, Inc. (NASDAQ:AKRX) earned “Buy” rating by Nomura on Wednesday, December 2. The stock of Akorn, Inc. (NASDAQ:AKRX) earned “Overweight” rating by JP Morgan on Monday, March 14. The stock has “Neutral” rating by Susquehanna on Wednesday, March 23. William Blair maintained Akorn, Inc. (NASDAQ:AKRX) on Wednesday, March 23 with “Outperform” rating. The stock of Akorn, Inc. (NASDAQ:AKRX) earned “Buy” rating by Jefferies on Wednesday, March 23.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Twitter Auto Publish Powered By : XYZScripts.com